Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Affolter A, Helmbrecht S, Finger S, Hormann K, Gotte K (2005) Altered expression of cell cycle regulators p21, p27, and p53 in tumors of salivary glands and paranasal sinuses. Oncol Rep 13(6):1089–194
Agulnik M and Siu LL (2004) An update on the systemic therapy of malignant salivary gland cancers: role of chemotherapy and molecular targeted agents. Curr Med Chem Anticancer Agents 4(6):543–551
Armstrong JG, Harrison LB, Thaler HT, Friedlander-Klar H, Fass DE, Zelefsky MJ, Shah JP, Strong EW, and Spiro RH (1992) The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 69(3):615–619
Bardwil J (1967) Tumors of the parotid gland. Am J Surg 114:498–502
Batsakis JG (1986) Carcinomas of the submandibular and sublingual glands. Ann Otol Rhinol Laryngol 95(2 Pt 1):211–212
Bhattacharyya N and Fried MP (2002) Nodal metastasis in major salivary gland cancer: predictive factors and effects on survival. Arch Otolaryngol Head Neck Surg 128(8):904–908
Bilal H, Handra-Luca A, Bertrand JC, and Fouret PJ (2003) P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem Cytochem 51(2):133–139
Bosch A, Brandenburg JH, and Gilchrist KW (1980) Lymph node metastases in adenoid cystic carcinoma of the submaxillary gland. Cancer 45(11):2872–2877
Bui CD, Ching AS, Carlos RC, Shreve PD, and Mukherji SK (2003) Diagnostic accuracy of 2-[fluorine-18]fluro-2-deoxy-D-glucose positron emission tomography imaging in nonsquamous tumors of the head and neck. Invest Radiol 38(9):593–601
Califano L, Zupi A, Massari PS, and Giardino C (1993) Indication for neck dissection in carcinoma of the parotid gland. Our experience on 39 cases. Int Surg 78(4):347–349
Chou C, Zhu G, Luo M, and Xue G (1996) Carcinoma of the minor salivary glands: results of surgery and combined therapy. J Oral Maxillofac Surg 54(4):448–453
Darling MR, Schneider JW, and Phillips VM (2002) Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers. Oral Oncol 38(7):641–645
Emanuel P, Wang B, Wu M, and Burstein DE (2005) p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol 18(5):645–650
Etges A, Pinto DS, Jr., Kowalski LP, Soares FA, Araujo VC (2003) Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour. J Clin Pathol 56(12):914–918
Fan CY, Melhem MF, Hosal AS, Grandis JR, and Barnes EL (2001) Expression of androgen receptor, epidermal growth factor receptor, and transforming growth factor alpha in salivary duct carcinoma. Arch Otolaryngol Head Neck Surg 127(9):1075–1079
Ferlito A, Pellitteri PK, Robbins KT, Shaha AR, Kowalski LP, Silver CE, Anniko M, Rinaldo A, Medina JE, Bradley PJ, and Byers RM (2002) Management of the neck in cancer of the major salivary glands, thyroid and parathyroid glands. Acta Otolaryngol 122(6):673–678
Ferlito A, Shaha AR, Rinaldo A, and Mondin V (2001) Management of clinically negative cervical lymph nodes in patients with malignant neoplasms of the parotid gland. ORL J Otorhinolaryngol Relat Spec 63(3):123–126
Foschini MP, Gaiba A, Cocchi R, Pennesi MG, and Pession A (2005) p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation. Int J Surg Pathol 13(4):329–335
Frankenthaler RA, Byers RM, Luna MA, Callender DL, Wolf P, and Goepfert H (1993) Predicting occult lymph node metastasis in parotid cancer. Arch Otolaryngol Head Neck Surg 119(5):517–520
Garden AS, el-Naggar AK, Morrison WH, Callender DL, Ang KK, and Peters LJ (1997) Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys 37(1):79–85
Garden AS, Weber RS, Ang KK, Morrison WH, Matre J, and Peters LJ (1994) Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer 73(10):2563–2569
Johns ME (1980) Parotid cancer: a rational basis for treatment. Head Neck Surg 3(2):132–141
Kawahara A, Harada H, Yokoyama T, and Kage M (2005) p63 Expression of clear myoepithelial cells in epithelialmyoepithelial carcinoma of the salivary gland: a useful marker for naked myoepithelial cells in cytology. Cancer 105(4):240–245
Kelley DJ and Spiro RH (1996) Management of the neck in parotid carcinoma. Am J Surg 172(6):695–697
Keyes JW Jr., Harkness BA, Greven KM, Williams DW, 3rd, Watson NE Jr., and McGuirt WF (1994) Salivary gland tumors: pretherapy evaluation with PET. Radiology 192(1):99–102
Kishi M, Nakamura M, Nishimine M, Ikuta M, Kirita T, and Konishi N (2005) Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas. Oral Oncol 41(2):161–169
Korkmaz H, Yoo GH, Du W, Hocwald E, Otero-Garcia JE, Volkan Adsay N, Shibuya T, and Jacobs JR (2002) Predictors of nodal metastasis in salivary gland cancer. J Surg Oncol 80(4):186–189
Krause CJ (1981) The management of parotid neoplasms. Head Neck Surg 3(4):340–343
Laskawi R, Rodel R, Zirk A, and Arglebe C (1998) Retrospective analysis of 35 patients with acinic cell carcinoma of the parotid gland. J Oral Maxillofac Surg 56(4):440–443
Layfield LJ and Gopez EV (2002) Cystic lesions of the salivary glands: cytologic features in fine-needle aspiration biopsies. Diagn Cytopathol 27(4):197–204
Licitra L, Grandi C, Prott FJ, Schornagel JH, Bruzzi P, and Molinari R (2003) Major and minor salivary glands tumours. Crit Rev Oncol Hematol 45(2):215–225
Lim JJ, Kang S, Lee MR, Pai HK, Yoon HJ, Lee JI, Hong SP, and Lim CY (2003) Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med 32(9):552–651
Lopes MA, Santos GC, and Kowalski LP (1998) Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head Neck 20(8):699–706
Ma DQ and Yu GY (1987) Tumours of the minor salivary glands. A clinicopathologic study of 243 cases. Acta Otolaryngol 112:106–109
Maruya S, Kies MS, Williams M, Myers JN, Weber RS, Batsakis JG, and El-Naggar AK (2005) Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications. Hum Pathol 36(7):821–827
McGuirt WF (1989) Management of occult metastatic disease from salivary gland neoplasms. Arch Otolaryngol Head Neck Surg 115(3):322–325
Nagler RM, Kerner H, Ben-Eliezer S, Minkov I, and Ben-Itzhak O (2003) Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies. Oncology 64(4):389–398
Nasser SM, Faquin WC, and Dayal Y (2003) Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol 119(6):801–806
Otsuka H, Graham MM, Kogame M, and Nishitani H (2005) The impact of FDG-PET in the management of patients with salivary gland malignancy. Ann Nucl Med 19(8):691–694
Pedersen D, Overgaard J, Sogaard H, Elbrond O, and Overgaard M (1992) Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis. Laryngoscope 102(9):1064–1069
Pohar S, Gay H, Rosenbaum P, Klish D, Bogart J, Sagerman R, Hsu J, and Kellman R (2005) Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes. Int J Radiat Oncol Biol Phys 61(1):112–118
Potencz E, Cornianu M, Muntean C, and Sotiriadis S (1998) The expression of p53 protein in salivary gland carcinomas. Rom J Morphol Embryol 44(1–4):109–115
Poulsen MG, Tripcony LB, and Kynaston B (1991) Nodal recurrence in primary malignant epithelial tumours of the parotid gland. Australas Radiol 35(2):169–173
Regis De Brito Santos I, Kowalski LP, Cavalcante De Araujo V, Flavia Logullo A, and Magrin J (2001) Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. Arch Otolaryngol Head Neck Surg 127(1):56–60
Seethala RR, LiVolsi VA, and Baloch ZW (2005) Relative accuracy of fine-needle aspiration and frozen section in the diagnosis of lesions of the parotid gland. Head Neck 27(3):217–223
Seethala RR, LiVolsi VA, Zhang PJ, Pasha TL, Baloch ZW (2005) Comparison of p63 and p73 expression in benign and malignant salivary gland lesions. Head Neck 27(8):696–702
Shah JP (1990) Cervical lymph node metastases-diagnostic, therapeutic, and prognostic implications. Oncology (Williston Park) 4(10):61–9; discussion 72, 76
Spiro RH (1986) Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 8(3):177–184
Spiro RH (1995) Changing trends in the management of salivary tumors. Semin Surg Oncol 11(3):240–245
Spiro RH, Huvos AG, Berk R, and Strong EW (1978) Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. Am J Surg 136(4):461–8
Spiro RH, Huvos AG, and Strong EW (1974) Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases. Am J Surg 128(4):512–520
Spiro RH, Huvos AG, and Strong EW (1975) Cancer of the parotid gland. A clinicopathologic study of 288 primary cases. Am J Surg 130(4):452–459
Stanley MW (2002) Selected problems in fine needle aspiration of head and neck masses. Mod Pathol 15(3):342–350
Stennert E, Kisner D, Jungehuelsing M, Guntinas-Lichius O, Schroder U, Eckel HE, and Klussmann JP (2003) High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg 129(7):720–723
Stewart CJ, MacKenzie K, McGarry GW, and Mowat A (2000) Fine-needle aspiration cytology of salivary gland: a review of 341 cases. Diagn Cytopathol 22(3):139–146
Storey MR, Garden AS, Morrison WH, Eicher SA, Schechter NR, and Ang KK (2001) Postoperative radiotherapy for malignant tumors of the submandibular gland. Int J Radiat Oncol Biol Phys 51(4):952–958
Sugano S, Mukai K, Tsuda H, Hirohashi S, Furuya S, Shimosato Y, Ebihara S, and Takeyama I (1992) Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Laryngoscope 102(8):923–927
Sung MW, Kim KH, Kim JW, Min YG, Seong WJ, Roh JL, Lee SJ, Kwon TK, and Park SW (2003) Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 129(11):1193–1197
Terhaard CH, Lubsen H, Rasch CR, Levendag PC, Kaanders HH, Tjho-Heslinga RE, van Den Ende PL, and Burlage F (2005) The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 61(1):103–111
Theriault C and Fitzpatrick PJ (1986) Malignant parotid tumors. Prognostic factors and optimum treatment. Am J Clin Oncol 9(6):510–516
Uchida Y, Minoshima S, Kawata T, Motoori K, Nakano K, Kazama T, Uno T, Okamoto Y, and Ito H (2005) Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Clin Nucl Med 30(3):170–176
Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Loftus-Coll BM, Keus RB, and Hart AA (1999) Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors. Cancer 85(10):2255–2264
Zbaren P, Nuyens M, Loosli H, and Stauffer E (2004) Diagnostic accuracy of fine-needle aspiration cytology and frozen section in primary parotid carcinoma. Cancer 100(9):1876–1883
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gendron, K.B., Ferris, R.L. (2007). Management of the Neck in Cancer of the Salivary Glands. In: Myers, E.N., Ferris, R.L. (eds) Salivary Gland Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-47072-4_25
Download citation
DOI: https://doi.org/10.1007/978-3-540-47072-4_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-47070-0
Online ISBN: 978-3-540-47072-4
eBook Packages: MedicineMedicine (R0)